DHL sees significant growth in Life Sciences and Healthcare products in Asia

•Growth attributed to rising demand in Asia, particularly in markets like China •Shipment of pharmaceuticals, vaccines, medical equipment and clinical trials by DHL Life Sciences & Healthcare Global Customer Solutions grew double digit in 2009
By: Blue Lotus PR
 
April 20, 2010 - PRLog -- DHL, the world’s leading logistics company, saw a record number of movements of healthcare products in 2009 in Asia. Compared to 2008, shipment of finished pharmaceuticals, vaccines, medical equipment and devices and clinical trials facilitated by the DHL Life Sciences & Healthcare Global Customer Solutions grew overall by seven per cent, a steady growth despite the economic downturn.

Sue Arden, Vice President, Global Customer Solutions, Life Sciences & Healthcare, DHL Asia Pacific, said “Two major factors driving this growth are the rising demand for healthcare in fast-expanding economies such as China and India, as well as the rapidly ageing populations in countries such as Japan, South Korea, Australia, Taiwan and Singapore. The growth trend is not surprising given the increasing demand for quality healthcare and affluence in Asia.  By 2014, China and India will make up 50 percent of the world’s population.”

According to Datamonitor, pharmaceutical sales in Asia Pacific amounted to USD$124.3 billion in 2009 representing 19.3 per cent of global sales. Sales are projected to grow steadily at a compound annual growth rate (CAGR) that exceeds 4.2 per cent from 2009 to 2014, reaching USD$153 billion. From 2005 to 2009, the China market grew the fastest with a CAGR of 21.1 per cent and is projected to grow rapidly at a CAGR of 9.7 per cent from 2009 to 2014.


Arden said: “The establishment of DHL’s first China Competence Centre in Pudong International Airport, Shanghai and a second scheduled to open within 2010 in Tianjin is a clear testament to the growing demand and opportunity we see in this sector”.

In Australia, DHL completed a US$32 million ‘State of the Art’ facility for air & ocean handling at Melbourne airport in late 2009. The facility houses the new healthcare ‘Competence Center’ comprising of 50,000 square meters and includes two cool rooms that meet GMP/TGA Standard (high FDA equivalent industry standards) for the sole purpose of handling controlled ambient and temperature sensitive products.

She added: “In 2009 the organization further committed to invest US$15 million to develop the Competence Centers in India, Mumbai and Hyderabad targeted as the primary sites, and facility expansion in Singapore. We recognize that Singapore, known for its strong research facilities, not only manufactures pharmaceutical products but is also a key transportation hub receiving pharmaceutical products inbound from major manufacturing sources and providing storage and onward distribution service to Asia. The DHL Life Science Competence Centre in Singapore serves to support the thriving pharmaceutical industry and the Singapore Government’s goal of having at least 10 multi-national production facilities in operation by 2010.”

In Singapore, there are more than 30 leading biomedical sciences companies with their regional headquarters here and the Singapore Government is targeting US$17 billion in biosciences manufacturing output by 20152.

Arden added there has been an increase in the demand for quality transportation of temperature sensitive products requiring either controlled ambient or more stringent temperature monitoring.

Vaccines have emerged as one of the growth segments in the global pharmaceutical industry. With a projected CAGR of over 13 per cent from 2009 to 2012, the industry will emerge as the fastest growing sector3. The US and Europe represent the two largest vaccine markets in the world and will continue experiencing healthy growth rate in future.

DHL’s global 2015 strategy is to be the ‘Logistics Provide of Choice’ with continued investment in quality infrastructure, people and processes, DHL Life Sciences & Healthcare look to be in the driving seat.


1 Datamonitor
2 Business Monitor International Ltd., Executive Summery, Singapore Pharmaceuticals & Healthcare Report Q4 2009, September 2009, Pg. 7
3 Global Vaccine Market Forecast 2012


Media Contact:

Blue Lotus Communications Pvt. Ltd.
Petrina Fernandes / Wayne Ferrao
Tel: +91 9820426841 / 9833052002
Email: petrina@bluelotuspr.com
wayne@bluelotuspr.com


DHL – The Logistics company for the world
DHL is the global market leader in the logistics industry and “The Logistics company for the world”. DHL commits its expertise in international express, air and ocean freight, road and rail transportation, contract logistics and international mail services to its customers. A global network composed of more than 220 countries and territories and about 300,000 employees worldwide offers customers superior service quality and local knowledge to satisfy their supply chain requirements. DHL accepts its social responsibility by supporting climate protection, disaster management and education.

DHL is part of Deutsche Post DHL. The Group generated revenue of more than 46 billion euros in 2009.

# # #

Blue Lotus Communications are Communication Consultants with an array of health care, technology and finance clients. The other businesses of the group include a design boutique called Mustard Designs and Blue Bytes, an Information Logistics service.
End
Source:Blue Lotus PR
Email:***@bluelotuspr.com Email Verified
Zip:411009
Tags:Dhl, Life Sciences, Health Care, Pharmaceuticals, Vaccines, Medical Equipment
Industry:Logistics, Life sciences, Medical
Location:Maharashtra - India
Account Email Address Verified     Disclaimer     Report Abuse
Blue Lotus Communications News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share